MDC/CCL22 intrathecal levels in patients with multiple sclerosis

Daniela Galimberti, C. Fenoglio, C. Comi, D. Scalabrini, M. De Riz, M. Leone, E. Venturelli, F. Cortini, M. Piola, F. Monaco, N. Bresolin, E. Scarpini

Research output: Contribution to journalArticle

Abstract

MDC/CCL22 has been detected in the brain of mice with experimental autoimmune encephalomyelitis. MDC/CCL22 cerebrospinal fluid levels were evaluated in 56 patients with multiple sclerosis (MS) and in 17 controls. No significant differences were found, even when stratifying patients according to the disease subtype. Stratifying by gender, significantly increased MDC/CCL22 levels were observed in female patients when compared with female controls and male patients (109.03 versus 98.54 and 99.37 pg/mL, P = 0.034 and 0.018, respectively). Therefore, MDC/CCL22 is likely to play a role in the development of MS in females only, possibly influencing the intracerebral recruitment of Th2 cells, which produce anti-inflammatory cytokines.

Original languageEnglish
Pages (from-to)547-549
Number of pages3
JournalMultiple Sclerosis Journal
Volume14
Issue number4
DOIs
Publication statusPublished - May 2008

Keywords

  • Cerebrospinal fluid
  • MDC/CCL22
  • Multiple sclerosis

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'MDC/CCL22 intrathecal levels in patients with multiple sclerosis'. Together they form a unique fingerprint.

  • Cite this